V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330001119 | 330000614 | 1.79 | 55 | Neo-adjuvant (N) | 2016-05-31 | 2016-06-15 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330002818 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001120 | 330000615 | null | 84.3 | Curative (C) | null | 2014-04-09 | Cisplatin | N | N | 330002822 | CISPLATIN |
| 330001121 | 330000615 | 1.39 | 91 | Disease modification (D) | 2015-03-16 | 2015-03-16 | EW EuroEwing 2012 Arm B VDC | Y | N | 330002822 | TRIAL |
| 330001122 | 330000615 | 1.65 | 16.1 | Neo-adjuvant (N) | 2015-08-26 | 2015-10-13 | Cisplatin | 02 | N | 330002822 | CISPLATIN |
| 330001123 | 330000615 | null | 71.7 | Curative (C) | 2013-07-04 | 2013-07-29 | Cisplatin | N | Y | 330002822 | CISPLATIN |
| 330001124 | 330000616 | 1.89 | 72.8 | Palliative (P) | 2017-12-15 | 2017-12-26 | Trial Unspecified | Y | N | 330002829 | TRIAL |
| 330001125 | 330000616 | 1.58 | 72.1 | Curative (C) | 2014-01-23 | 2014-02-02 | Cisplatin 7 day | 02 | N | 330002829 | CISPLATIN |
| 330001126 | 330000616 | 1.65 | 58.9 | Palliative (P) | 2013-10-28 | 2013-11-11 | Cisplatin | Y | Y | 330002829 | CISPLATIN |
| 330001127 | 330000616 | null | 50.7 | null | 2016-04-05 | 2016-04-15 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330002829 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001128 | 330000617 | 1.77 | 12.7 | Curative (C) | null | 2016-03-02 | Cisplatin + Docetaxel +Fluorouracil | null | null | 330002838 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001129 | 330000617 | null | 85 | Curative (C) | 2013-05-13 | 2013-05-21 | NB HRNBL-1 COJEC Ind COURSE A | 1 | N | 330002838 | NOT MATCHED |
| 330001130 | 330000618 | 1.7 | 83.5 | Curative (C) | 2016-10-04 | 2016-10-04 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330002844 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001131 | 330000619 | 1.78 | 5.2 | Curative (C) | 2013-10-31 | 2013-11-07 | Cisplatin 7 day | 02 | N | 330002845 | CISPLATIN |
| 330001132 | 330000620 | 0 | 62.5 | Curative (C) | 2014-06-23 | 2014-12-25 | Trial Unspecified | 01 | null | 330002853 | TRIAL |
| 330001133 | 330000620 | 0 | 27.4 | Curative (C) | null | 2016-05-28 | CYCLOPHOSPHAMIDE + RITUXIMAB + prednisolone | null | N | 330002853 | NOT MATCHED |
| 330001134 | 330000621 | null | 60.4 | Palliative (P) | 2015-12-21 | 2015-12-24 | STS Rhabdo RMS 2005 | Y | N | 330002858 | NOT MATCHED |
| 330001135 | 330000621 | null | 118 | Curative (C) | 2015-09-23 | 2015-09-25 | NB HRNBL-1 Isotretinoin | 02 | N | 330002858 | NOT MATCHED |
| 330001136 | 330000621 | 1.61 | 48.6 | Curative (C) | 2017-04-18 | 2017-04-27 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | N | 330002858 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001137 | 330000622 | 1.62 | 50.4 | Curative (C) | null | 2014-06-25 | Cisplatin 7 day | 01 | null | 330002861 | CISPLATIN |
| 330001138 | 330000623 | 1.62 | 42.6 | Curative (C) | null | 2015-08-18 | Cisplatin 7 day | N | Y | 330002862 | CISPLATIN |
| 330001139 | 330000623 | 1.7 | 58 | null | 2016-04-18 | 2016-05-01 | Cisplatin 7 day | null | Y | 330002862 | CISPLATIN |
| 330001140 | 330000623 | null | 73.3 | null | null | 2016-10-26 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330002862 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001141 | 330000624 | 1.68 | 54.9 | null | 2014-02-11 | 2014-03-04 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330002875 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001142 | 330000624 | null | 14 | Curative (C) | 2015-11-26 | 2015-12-04 | NB HRNBL-1 COJEC Ind COURSE A | 2 | Y | 330002875 | NOT MATCHED |
| 330001143 | 330000625 | null | 90 | Neo-adjuvant (N) | 2016-03-10 | 2016-03-11 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330002879 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001144 | 330000626 | 1.75 | 53.5 | Neo-adjuvant (N) | 2014-11-28 | 2014-12-06 | Cisplatin + Docetaxel +Fluorouracil | 2 | null | 330002884 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001145 | 330000627 | 1.62 | 81.2 | Adjuvant (A) | 2016-09-11 | 2016-10-10 | Cisplatin 7 day | N | N | 330002887 | CISPLATIN |
| 330001146 | 330000628 | 1.79 | null | Curative (C) | 2015-08-07 | 2015-08-09 | Cisplatin 7 day | N | null | 330002888 | CISPLATIN |
| 330001147 | 330000629 | null | null | Curative (C) | 2017-09-27 | 2017-09-29 | null | N | N | 330002890 | NOT MATCHED |
| 330001148 | 330000630 | 0 | 20 | Curative (C) | 2015-11-25 | 2015-11-27 | EW EuroEwing 2012 Arm A VAC | N | null | 330002893 | NOT MATCHED |
| 330001149 | 330000631 | 1.54 | 5.5 | Curative (C) | 2014-08-31 | 2014-08-31 | NB HRNBL-1 COJEC Ind COURSE A | Y | null | 330002895 | NOT MATCHED |
| 330001150 | 330000632 | 1.62 | 44.4 | Curative (C) | 2014-08-06 | 2014-09-01 | Cisplatin 7 day | N | Y | 330002898 | CISPLATIN |
| 330001151 | 330000633 | 1.85 | null | Curative (C) | 2014-12-28 | 2015-01-10 | Cisplatin | N | N | 330002899 | CISPLATIN |
| 330001152 | 330000634 | 1.69 | 27.4 | Neo-adjuvant (N) | 2014-07-10 | 2014-07-15 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330002900 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001153 | 330000634 | 1.73 | 19.8 | Curative (C) | 2017-05-22 | 2017-06-07 | Cisplatin | 02 | Y | 330002900 | CISPLATIN |
| 330001154 | 330000635 | 1.76 | 67.5 | Not known (9) | 2013-02-12 | 2013-02-17 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | N | 330002909 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001155 | 330000636 | null | 75.3 | Curative (C) | 2015-10-10 | 2015-10-10 | null | N | N | 330002910 | NOT MATCHED |
| 330001156 | 330000636 | 1.8 | 13.9 | Curative (C) | 2013-11-02 | 2013-11-03 | Cisplatin | N | Y | 330002910 | CISPLATIN |
| 330001157 | 330000636 | 1.72 | null | Curative (C) | 2017-11-27 | 2017-12-26 | Cisplatin | N | Y | 330002910 | CISPLATIN |
| 330001158 | 330000636 | null | 99.5 | null | 2014-02-01 | 2014-02-01 | NB Low/Interm risk guidelines Carbo/Etop | Y | N | 330002910 | NOT MATCHED |
| 330001159 | 330000636 | 1.76 | 87.5 | Adjuvant (A) | 2016-02-10 | 2016-03-08 | Cisplatin | N | Y | 330002910 | CISPLATIN |
| 330001160 | 330012612 | 1.68 | null | Neo-adjuvant (N) | null | 2016-09-27 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 330002931 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001161 | 330012612 | 1.35 | 80 | Palliative (P) | 2017-10-10 | 2017-10-10 | EW EuroEwing 2012 Arm B VDC | N | null | 330002931 | TRIAL |
| 330001162 | 330000637 | null | 74.4 | Curative (C) | 2015-05-20 | 2015-05-22 | AML MyeChild | 02 | N | 330002935 | NOT MATCHED |
| 330001163 | 330000638 | 1.7 | 28.1 | Curative (C) | 2017-06-29 | 2017-07-12 | Cisplatin | N | null | 330002937 | CISPLATIN |
| 330001164 | 330000639 | null | null | Curative (C) | 2015-11-10 | 2015-11-10 | Cisplatin 7 day | N | Y | 330002938 | CISPLATIN |
| 330001165 | 330000639 | 1.89 | 34 | Curative (C) | 2018-02-05 | 2018-02-26 | EW EuroEwing 2012 Arm B VDC | 01 | N | 330002938 | TRIAL |
| 330001167 | 330000641 | 1.78 | 80.95 | null | 2017-06-28 | 2017-07-11 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 330002944 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001169 | 330006414 | null | 15.4 | Adjuvant (A) | 2013-01-18 | 2013-11-05 | CNS GCT II Non Germin - Std PEI | Y | Y | 330002949 | NOT MATCHED |
| 330001170 | 330000643 | 1.8 | 75.7 | Curative (C) | null | 2015-05-14 | Cisplatin 7 day | 02 | Y | 330002951 | CISPLATIN |